Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAALADL2 antisense RNA 3 (non-protein coding) (NAALADL2-AS3)
- Target
- NAALADL2-AS3
- Molecular classification
- Other (long non-coding RNA; lncRNA)
01
Overview
NAALADL2 antisense RNA 3 (NAALADL2-AS3) is a long non-coding RNA transcribed from an antisense genomic region adjacent to or overlapping the NAALADL2 gene locus on chromosome 3[8][4][6]. It is classified as a non-protein coding RNA and its biological function, regulatory mechanism, and clinical relevance have not been established. Unlike its paralog NAALADL2-AS2, which has been investigated as a regulator in diffuse large B-cell lymphoma and prostate cancer[1][5], NAALADL2-AS3 does not have published studies demonstrating its molecular interactions, disease implications, or therapeutic potential. Current information regarding NAALADL2-AS3 is limited to gene location and classification. Therefore, NAALADL2-AS3 should not be considered a validated therapeutic target, biomarker, or drug interaction partner in the present state of knowledge[8]. If you need structured information, you should focus on NAALADL2-AS2 or NAALADL2 itself, as these have been covered in biomedical literature as therapeutic targets and biomarkers[1][5][9].
- Other names
- NAALADL2-AS3NAALADL2 antisense RNA 3NAALADL2 antisense RNA 3 (non-protein coding)
Beyond the preview
Go deeper on NAALADL2 antisense RNA 3 (non-protein coding) (NAALADL2-AS3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NAALADL2 antisense RNA 3 (non-protein coding) (NAALADL2-AS3).